News blog
Answer found for cancer drug failure
A recently approved cancer drug hailed as a miracle worker for some patients with advanced melanoma, has mysteriously failed in early clinical trials against colon cancers. But work published today in Nature clarifies how colon cancers dodge the drug, called vemurafenib, and what can be done to overcome this resistance.
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells